– Oversubscribed Series B round led by TPG includes prominent group of new and existing investors, bringing total raised to-date to over $110 million– Funding supports rapid clinical development of targeted ADC therapeutics in difficult-to-treat cancers – Chris LeMasters joins as Independent Board Member, bringing 2.
Eset Research: Iran-Aligned Ballistic Bobcat Targets Businesses In Israel With A New Backdoor menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Phase 2/3 results show that the bivalent second booster that targets both the original virus and the Omicron variant was superior to the standard booster a month after vaccination across age groups.